Health Care / Hospitals
Releases published in the last 30 days. 
Page 3 of 3
- BHTY Unveils 2025 Research Compendium Advancing Global Leadership in Blockchain, AI, and Digital Health
- 3/30/2026 8:00:00 AM
- Blockchain in Healthcare Today (BHTY) today announced the release of its 2025 Research Compendium, featuring all original research articles published this year alongside the complete archive of peer reviewed research since the journal’s launch.
- CMS launches model to improve care coordination for children and families
- 3/27/2026 10:01:01 AM
- The American Medical Association (AMA) welcomed a newly announced care model from the Centers for Medicare & Medicaid Services (CMS) designed to help Medicaid families better navigate and coordinate their health care.
- City of Stockholm signs agreement with Tieto Caretech on digital system and support for municipal welfare services
- 3/26/2026 11:30:58 AM
- Tieto Caretech will deliver their Lifecare solutions and related system support, to service providers within social services, elderly care, and municipal healthcare in the City of Stockholm.
- Activating Your Brain While Sitting Helps Reduce Dementia Risk
- 3/26/2026 11:08:15 AM
- New research distinguishing between passive and mentally active sitting in association with dementia has found that adults who engaged in extended durations of mentally passive sedentary behaviors had a higher risk of dementia.
- AMA launches nutrition education initiative
- 3/25/2026 10:52:11 AM
- The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.
- Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
- 3/24/2026 1:40:24 PM
- • Approval in moderate-to-severe patients was based on pivotal study results showing over four times more Dupixent patients experienced sustained disease remission through Week 36 compared with placebo • BP is a chronic, relapsing skin disease with underlying type 2 inflammation characterized by intense itch alongside painful blisters and other lesions • BP is the …
- « Previous
- 1
- 2
- 3
- Next »